VitalNext Overview
- Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Series B
- Investors
-
7
VitalNext General Information
Description
Provider of innovative life science products intended to offer health benefits to the aging population. The company's products build a bridge between the products and the market for consumer products that aid in living longer in a healthy way and provide preclinical and clinical development programs to generate value for the products, enabling people to stay aware of and enjoy healthy aging and to stay in good health for prolonged periods of time.
Contact Information
Website
www.vitalnext.nl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Personal Products
Drug Discovery
Primary Office
- J.H. Oortweg 19
- 2333 CH Leiden
- Netherlands
+31 071 000 0000
VitalNext Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 07-Oct-2020 | 00.000 | Completed | Generating Revenue | ||
| 3. Early Stage VC | 25-Feb-2016 | 00.000 | Completed | Generating Revenue | ||
| 2. Grant | 05-Nov-2013 | $273K | $1.98M | Completed | Startup | |
| 1. Early Stage VC | 04-Jul-2013 | $1.98M | $1.98M | Completed | Startup |
VitalNext Patents
VitalNext Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2016282923-B2 | Compositions and methods for the treatment of malnutrition | Active | 26-Jun-2015 | 00000000000 | |
| EP-3313207-B1 | Compositions and methods for the treatment of malnutrition | Active | 26-Jun-2015 | 00000000000 | 0 |
| EP-3313207-A1 | Compositions and methods for the treatment of malnutrition | Active | 26-Jun-2015 | 00000000000 | |
| ES-2775610-T3 | Compositions and methods for treating malnutrition | Active | 26-Jun-2015 | 00000000000 | |
| JP-6851086-B2 | Compositions and methods for treating malnutrition | Active | 26-Jun-2015 | A61K38/1709 |
VitalNext Executive Team (4)
VitalNext Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dharminder Chahal | Self | Supervisory Board Member | 000 0000 |
| Rudy Mareel | Self | Executive Chairman | 000 0000 |
| Willem De Vos Ph.D | Self | Supervisory Board Member | 000 0000 |
VitalNext Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| LRM | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Oost NL | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Samenwerkingsverband Noord-Nederland | Government | Minority | 000 0000 | 000000 0 | |
| Galapagos (Biotechnology) | Corporation | Minority | 000 0000 | 000000 0 | |
| Hanzepoort | Venture Capital | Minority | 000 0000 | 000000 0 |